Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Effectiveness of Tecar Therapy in Management of Calf Muscle Strain Injuries (MS)

25. april 2026 opdateret af: Nabil Mahmoud Ismail Abdel-Aal, Cairo University
this study will be conducted to investigate the effect of TECAR Therapy on quality of landing, healing and Function in patient with Calf Muscle Strain.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Calf muscle strain is one of the most common muscle injuries in high-performance athletes and contributes to substantial player downtime because of its high mean time to return to sport and occurrence during critical periods in the competitive season. Published reports on lower-body muscle strain have provided frequent updates on the rehabilitation of high-profile muscle groups, such as the hamstring muscles, and improvements to calf strain management are seldom discussed despite the prevalence of these injuries in competitive sports. In this article, we discuss the diagnosis, treatment, outcomes, risk factors, and prevention of calf muscle strain in athletes.Transfer of Electricity-Capacitive and Resistive (Tecar) therapy is considered a special form of energy that uses frequencies between 300 KHz and 1 MHz and is characterized as a non-invasive high-frequency energy that awakens the body's natural ability to self-regenerate. Thus, it promotes the natural physiological processes of the tissue metabolically, transferring energy without introducing radiation from the external environment. TECAR therapy stands out as a promising yet underexplored modality. Its mechanism of action-utilizing both capacitive and resistive energy transfer-suggests a novel approach to addressing musculoskeletal injuries and pain. While preliminary studies and clinical applications hint at its potential advantages, such as improved tissue healing and pain relief, a comprehensive evaluation of the existing research is necessary to fully understand the role of TECAR therapy in rehabilitation

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Aged between 16-39 years of age.
  • not having suffered leg injuries in the past 6 months.
  • not having suffered a triceps sural rupture in the past two years.
  • be diagnosed with latent MTPs in the gastric-soleus complex through manual therapy in the dominant side.
  • Presence of Calf muscles Strain evaluated by Ultrasonography.
  • Athlete willing and able to participate in an exercise program safely.
  • The radiologist also assessed whether the tendon ends could be reduced in passive plantar flexion of the ankle joint with the knee extended.
  • Athlete BMI from 18.5 to 24.9 kg / m2

Exclusion Criteria:

  • connective tissue pathology.
  • lymphatic disorders (lymphadenopathy).
  • Skin injuries (open wounds, infection, psoriasis, tattoos, hematoma).
  • peripheral neuropathies.
  • previous fractures.
  • previous lower limb surgeries (in the past 12 months).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: TECAR therapy
Thirty patients will receive TECAR therapy combined with conventional treatment three times per week for 12 weeks.
Andet: TECAR therapy
The TECAR intervention was administered to the calf muscle using the Zimmer devicein capacitive (CAP) mode for a duration of 20 min. The therapy was applied with the signal at a variable power with a maximum of 300 W. The frequency used was 500 kHz with an intensity of 40%. The intervention was standardized to a distal-to-proximal stroking rhythm with moderate pressure. For the TECAR intervention, the capacitive (CAP) mode at 500 kHz with 40% intensity and a maximum power of 300 W was chosen to optimize deep tissue heating and promote local blood flow and tissue recovery. The 20 min duration reflects protocols commonly used in therapeutic settings for muscle recovery and rehabilitation plus conventional therapy
Andet: conventional treatment
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.
Aktiv komparator: conventional treatment
Thirty patients will receive conventional treatment three times per week for 12 weeks.
Andet: conventional treatment
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
size of injury
Tidsramme: up to 12 weeks
ultrasonography device will be used to assess size of injury
up to 12 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
landing error score system
Tidsramme: up to 12 weeks
Landing Error Scoring System is a clinical tool used to assess jump-landing mechanics for the video from my jumb land aplication . the feet, ankle, knees, hip, trunk, shoulder, neck and head posture is assessed through the video. it is a 17-item . According to the performance sheet, the questions 1-15 are Yes/No questions that are rated as 0 or 1. The questions 16 are rated as 0, 1, and 2; 0 = soft, 1= average and 2= stiff. the question 17 are rated as 0,1,2; 0= excellent,1 average and 2= poor, so the total score ranges from zero to 19. A higher score indicates poor technique in landing from a jump; a lower score indicates better jump-landing technique. the score are categorized as excellent which less than 4, good score more than four and less than or equal 5, moderate score less than four and poor more than six
up to 12 weeks
jump height
Tidsramme: up to 12 weeks
The vertical jump test was performed as a one-legged counter movement jump (CMJ). Starting position was in an upright position with the hands placed behind the back. The subjects quickly bent the knee as much as desired and then immediately jumped upward attempting to maximize the height jumped. The subjects performed three maximal approved trials for each leg, starting with the right and alternating between the right and the left leg. However, if the subject increased hop performance in all three jumps, additional jumps were performed until no increase was seen. The best jump height for each leg was used for data analysis.
up to 12 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Cairo University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. maj 2026

Primær færdiggørelse (Anslået)

1. december 2026

Studieafslutning (Anslået)

1. december 2026

Datoer for studieregistrering

Først indsendt

25. april 2026

Først indsendt, der opfyldte QC-kriterier

25. april 2026

Først opslået (Faktiske)

1. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

1. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

25. april 2026

Sidst verificeret

1. april 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • P.T.REC/012/006406

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner